首页 > 最新文献

Research and Practice in Thrombosis and Haemostasis最新文献

英文 中文
HTRS2025.O8A.6 The heme-induced mitochondrial oxidant-dependent platelet secretome promotes endothelial dysfunction HTRS2025.O8A.6血红素诱导的线粒体氧化依赖性血小板分泌组促进内皮功能障碍
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103146
Gowtham K. Annarapu , Venkat Ramakrishna Ungarala , Deirdre Nolfi-Donegan , Sruti Shiva
{"title":"HTRS2025.O8A.6 The heme-induced mitochondrial oxidant-dependent platelet secretome promotes endothelial dysfunction","authors":"Gowtham K. Annarapu , Venkat Ramakrishna Ungarala , Deirdre Nolfi-Donegan , Sruti Shiva","doi":"10.1016/j.rpth.2025.103146","DOIUrl":"10.1016/j.rpth.2025.103146","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 103146"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HTRS2025.O6B.2 Abstract Travel Award Platelet RIG-I promotes Flu-Induced Severe Lung Injury in Sickle Cell Disease HTRS2025.O6B.2Travel Award血小板rig - 1促进流感诱导的镰状细胞病严重肺损伤
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103130
Tomasz W. Kaminski , Omika Katoch , Nicholas Swendrowski , Prithu Sundd
{"title":"HTRS2025.O6B.2 Abstract Travel Award Platelet RIG-I promotes Flu-Induced Severe Lung Injury in Sickle Cell Disease","authors":"Tomasz W. Kaminski , Omika Katoch , Nicholas Swendrowski , Prithu Sundd","doi":"10.1016/j.rpth.2025.103130","DOIUrl":"10.1016/j.rpth.2025.103130","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 103130"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HTRS2025.P1.4 Current Clinical Practices in HTCs for Identifying, Classifying and Providing Care to Hemophilia Carriers HTRS2025.P1.4血友病携带者hcc识别、分类及护理的临床现状
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103024
Susan Lattimore , Eleanor Carrick , J Nathan Hagstrom , Lisa Maiale-Howell
{"title":"HTRS2025.P1.4 Current Clinical Practices in HTCs for Identifying, Classifying and Providing Care to Hemophilia Carriers","authors":"Susan Lattimore , Eleanor Carrick , J Nathan Hagstrom , Lisa Maiale-Howell","doi":"10.1016/j.rpth.2025.103024","DOIUrl":"10.1016/j.rpth.2025.103024","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 103024"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HTRS2025.P1.40 Use of Therapeutic Plasma Exchange and/or Intravenous Immunoglobulin in Patients with Acute Heparin Induced Thrombocytopenia and Heparin Exposure During Cardiac Surgery HTRS2025.P1.40治疗性血浆置换和/或静脉注射免疫球蛋白在心脏手术中急性肝素诱导的血小板减少症和肝素暴露患者中的应用
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103060
Joshua P. Muniz , Abraham Attah , Nithin Thomas , Cheryl Maier
{"title":"HTRS2025.P1.40 Use of Therapeutic Plasma Exchange and/or Intravenous Immunoglobulin in Patients with Acute Heparin Induced Thrombocytopenia and Heparin Exposure During Cardiac Surgery","authors":"Joshua P. Muniz , Abraham Attah , Nithin Thomas , Cheryl Maier","doi":"10.1016/j.rpth.2025.103060","DOIUrl":"10.1016/j.rpth.2025.103060","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 103060"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HTRS2025.P1.44 Comparative Analysis of Perioperative Management of Antiplatelet Agent Guidelines across US Institutions HTRS2025.P1.44美国各机构抗血小板药物指南围手术期管理的比较分析
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103064
Ming Y. Lim , Jacob C. Cogan , Caroline Cromwell , Manila Gaddh , Radhika Gangaraju , Colleen Morton , Andrew Peseski , Rishabh Singh , Ishan Tatake , Kimberley Youkhana , Lisa Baumann Kreuziger
{"title":"HTRS2025.P1.44 Comparative Analysis of Perioperative Management of Antiplatelet Agent Guidelines across US Institutions","authors":"Ming Y. Lim , Jacob C. Cogan , Caroline Cromwell , Manila Gaddh , Radhika Gangaraju , Colleen Morton , Andrew Peseski , Rishabh Singh , Ishan Tatake , Kimberley Youkhana , Lisa Baumann Kreuziger","doi":"10.1016/j.rpth.2025.103064","DOIUrl":"10.1016/j.rpth.2025.103064","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 103064"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HTRS2025.O6C.3 Standardized Thromboembolism prophylaxis in Orthopedic Patients to prevent Venous ThromboEmbolism(STOP-VTE): Validation of a risk assessment model to prevent VTE in elective joint replacement patients HTRS2025.O6C.3骨科患者预防静脉血栓栓塞(STOP-VTE)的标准化血栓栓塞预防:预防选择性关节置换术患者静脉血栓栓塞的风险评估模型的验证
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103137
Scott C. Woller , Scott M. Stevens , Jim F. Lloyd , Li Dong , Benjamin Layne , David Turnbull , James D. Wylie , Nathan G. Momberger
{"title":"HTRS2025.O6C.3 Standardized Thromboembolism prophylaxis in Orthopedic Patients to prevent Venous ThromboEmbolism(STOP-VTE): Validation of a risk assessment model to prevent VTE in elective joint replacement patients","authors":"Scott C. Woller , Scott M. Stevens , Jim F. Lloyd , Li Dong , Benjamin Layne , David Turnbull , James D. Wylie , Nathan G. Momberger","doi":"10.1016/j.rpth.2025.103137","DOIUrl":"10.1016/j.rpth.2025.103137","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 103137"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145712072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health disinformation: a call to action for the hemostasis and thrombosis community 健康虚假信息:对止血和血栓社区的行动呼吁
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103272
David M. Smadja
The COVID-19 pandemic has exposed a parallel crisis: an infodemic of unprecedented scale and impact. This wave of misinformation and disinformation—particularly around thrombosis, vaccines, and hemostasis—has undermined public health measures, eroded institutional trust, and endangered scientific credibility. Within this hostile informational ecosystem, fringe theories proliferated across social media, falsely linking COVID-19 vaccines to widespread thrombosis via misinterpretations of D-dimer levels and anecdotal claims unsupported by clinical evidence. Political agendas, emotional manipulation, and algorithm-driven amplification created fertile ground for disinformation to thrive—especially among vulnerable populations like youth and vaccine-hesitant communities. The article dissects how belief bias, trust shortcuts, groupthink, and platform algorithms contributed to the viral spread of falsehoods about thrombosis and hemostasis. Case studies include the misuse of hydroxychloroquine, antivaccine conspiracy movements, and the misleading portrayal of rare vaccine-induced clotting events. The consequences were severe: declining vaccine uptake, harassment of scientists, and growing skepticism toward evidence-based medicine. This article calls on the hemostasis and thrombosis community to move beyond passive dissemination of knowledge. It proposes a 4-pillar strategy: embedding scientific voices in digital discourse, reforming media and health literacy education, enforcing stronger regulatory frameworks, and institutionalizing collective scientific engagement in mainstream and social media. As future health crises loom, communication must become as central as research itself. The article argues that the next battle for public health will be waged not only in hospitals and laboratories but also in the information spaces where truth competes with virality. It is time for science to go viral—for the right reasons.
2019冠状病毒病大流行暴露了一场平行的危机:一场规模和影响前所未有的信息大流行。这一波错误信息和虚假信息——尤其是关于血栓、疫苗和止血的——破坏了公共卫生措施,侵蚀了机构信任,并危及科学可信度。在这个充满敌意的信息生态系统中,边缘理论在社交媒体上扩散,通过对d -二聚体水平的误解和没有临床证据支持的轶事说法,将COVID-19疫苗与广泛的血栓形成错误地联系起来。政治议程、情绪操纵和算法驱动的放大为虚假信息的滋生创造了肥沃的土壤,尤其是在年轻人和对疫苗犹豫不决的社区等弱势群体中。这篇文章剖析了信仰偏见、信任捷径、群体思维和平台算法如何促成了关于血栓和止血的虚假信息的病毒式传播。案例研究包括误用羟氯喹、反疫苗阴谋运动以及对罕见疫苗引起的凝血事件的误导性描述。后果很严重:疫苗接种率下降,科学家受到骚扰,对循证医学的怀疑日益增加。这篇文章呼吁止血和血栓社区超越被动传播知识。它提出了一项四大支柱战略:将科学的声音纳入数字话语,改革媒体和卫生素养教育,实施更强有力的监管框架,以及将主流媒体和社交媒体的集体科学参与制度化。随着未来健康危机的逼近,交流必须变得和研究本身一样重要。这篇文章认为,公共卫生的下一场战斗不仅将在医院和实验室展开,还将在真相与病毒式传播竞争的信息空间展开。现在是科学传播病毒的时候了——出于正确的原因。
{"title":"Health disinformation: a call to action for the hemostasis and thrombosis community","authors":"David M. Smadja","doi":"10.1016/j.rpth.2025.103272","DOIUrl":"10.1016/j.rpth.2025.103272","url":null,"abstract":"<div><div>The COVID-19 pandemic has exposed a parallel crisis: an infodemic of unprecedented scale and impact. This wave of misinformation and disinformation—particularly around thrombosis, vaccines, and hemostasis—has undermined public health measures, eroded institutional trust, and endangered scientific credibility. Within this hostile informational ecosystem, fringe theories proliferated across social media, falsely linking COVID-19 vaccines to widespread thrombosis via misinterpretations of D-dimer levels and anecdotal claims unsupported by clinical evidence. Political agendas, emotional manipulation, and algorithm-driven amplification created fertile ground for disinformation to thrive—especially among vulnerable populations like youth and vaccine-hesitant communities. The article dissects how belief bias, trust shortcuts, groupthink, and platform algorithms contributed to the viral spread of falsehoods about thrombosis and hemostasis. Case studies include the misuse of hydroxychloroquine, antivaccine conspiracy movements, and the misleading portrayal of rare vaccine-induced clotting events. The consequences were severe: declining vaccine uptake, harassment of scientists, and growing skepticism toward evidence-based medicine. This article calls on the hemostasis and thrombosis community to move beyond passive dissemination of knowledge. It proposes a 4-pillar strategy: embedding scientific voices in digital discourse, reforming media and health literacy education, enforcing stronger regulatory frameworks, and institutionalizing collective scientific engagement in mainstream and social media. As future health crises loom, communication must become as central as research itself. The article argues that the next battle for public health will be waged not only in hospitals and laboratories but also in the information spaces where truth competes with virality. It is time for science to go viral—for the right reasons.</div></div>","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 8","pages":"Article 103272"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145748735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology, fibrinogen, clot properties, and cardiovascular disease risk—an African perspective 流行病学、纤维蛋白原、凝块特性和心血管疾病风险——非洲视角
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103266
Marlien Pieters , Zelda de Lange-Loots
A state of the art lecture titled “Epidemiology, fibrinogen, clot properties and cardiovascular disease risk: an African perspective” was presented at the International Society on Thrombosis and Haemostasis (ISTH) congress in 2025. Altered fibrin clot structure, characterized by tightly packed fibers, stiffer networks, and resistance to lysis, contributes to thrombosis. However, most of the available evidence comes from relatively small-sized observational, case-control studies or from animal models or in vitro studies. Much less is known regarding clot properties on population level. Epidemiological evidence may help determine lifestyle, demographic, and genetic factors as well as gene-environment interactions that can influence fibrinogen concentration and clot properties of a population. Most of the epidemiological evidence reported in this review comes from individuals from African descent. Similar to what has been observed in Europeans, we demonstrate that factors including obesity, dyslipidemia, inflammation, poor glycemic control, and aging-promoted prothrombotic clot properties, whereas higher high-density lipoprotein cholesterol and moderate alcohol intake were protective. Importantly, some of these factors had direct effects on clot properties, independent of fibrinogen concentration. Genetic analyses revealed distinct features in Africans compared with Europeans, including absence of common European haplotypes, novel variants, and reduced linkage disequilibrium, enabling the detection of unique gene-environment interactions in Africans. These gene-environment interactions not only influenced fibrinogen concentration but also modified clot properties and their responses to environmental and metabolic factors. Together, these findings emphasize the complexity of fibrinogen biology, the importance of functional clot properties in disease risk, and the need for population-specific studies to inform prevention strategies in Africa and globally. Finally, we summarize relevant new data on this topic presented during the 2025 ISTH Congress.
在2025年国际血栓和止血学会(ISTH)大会上发表了题为“流行病学、纤维蛋白原、凝块特性和心血管疾病风险:非洲视角”的最新讲座。纤维蛋白凝块结构的改变,其特点是纤维紧密堆积,网络更硬,抗溶解,有助于血栓形成。然而,大多数现有证据来自相对较小规模的观察性、病例对照研究、动物模型或体外研究。关于凝块在种群水平上的特性,我们所知甚少。流行病学证据可能有助于确定生活方式、人口统计学和遗传因素以及基因-环境相互作用,这些因素可以影响人群的纤维蛋白原浓度和凝块特性。本综述中报告的大多数流行病学证据来自非洲人后裔。与在欧洲观察到的结果相似,我们证明了包括肥胖、血脂异常、炎症、血糖控制不良和衰老促进的血栓前凝块特性在内的因素,而较高的高密度脂蛋白胆固醇和适度饮酒则具有保护作用。重要的是,其中一些因素对凝块特性有直接影响,而不依赖于纤维蛋白原浓度。遗传分析揭示了非洲人与欧洲人相比的独特特征,包括缺乏共同的欧洲单倍型、新的变异和减少的连锁不平衡,从而能够检测非洲人独特的基因-环境相互作用。这些基因与环境的相互作用不仅影响纤维蛋白原浓度,而且改变凝块性质及其对环境和代谢因素的反应。总之,这些发现强调了纤维蛋白原生物学的复杂性、功能性凝块特性在疾病风险中的重要性,以及开展针对特定人群的研究以为非洲和全球的预防战略提供信息的必要性。最后,我们总结了在2025年ISTH大会上提出的关于这一主题的相关新数据。
{"title":"Epidemiology, fibrinogen, clot properties, and cardiovascular disease risk—an African perspective","authors":"Marlien Pieters ,&nbsp;Zelda de Lange-Loots","doi":"10.1016/j.rpth.2025.103266","DOIUrl":"10.1016/j.rpth.2025.103266","url":null,"abstract":"<div><div>A state of the art lecture titled “Epidemiology, fibrinogen, clot properties and cardiovascular disease risk: an African perspective” was presented at the International Society on Thrombosis and Haemostasis (ISTH) congress in 2025. Altered fibrin clot structure, characterized by tightly packed fibers, stiffer networks, and resistance to lysis, contributes to thrombosis. However, most of the available evidence comes from relatively small-sized observational, case-control studies or from animal models or <em>in vitro</em> studies. Much less is known regarding clot properties on population level. Epidemiological evidence may help determine lifestyle, demographic, and genetic factors as well as gene-environment interactions that can influence fibrinogen concentration and clot properties of a population. Most of the epidemiological evidence reported in this review comes from individuals from African descent. Similar to what has been observed in Europeans, we demonstrate that factors including obesity, dyslipidemia, inflammation, poor glycemic control, and aging-promoted prothrombotic clot properties, whereas higher high-density lipoprotein cholesterol and moderate alcohol intake were protective. Importantly, some of these factors had direct effects on clot properties, independent of fibrinogen concentration. Genetic analyses revealed distinct features in Africans compared with Europeans, including absence of common European haplotypes, novel variants, and reduced linkage disequilibrium, enabling the detection of unique gene-environment interactions in Africans. These gene-environment interactions not only influenced fibrinogen concentration but also modified clot properties and their responses to environmental and metabolic factors. Together, these findings emphasize the complexity of fibrinogen biology, the importance of functional clot properties in disease risk, and the need for population-specific studies to inform prevention strategies in Africa and globally. Finally, we summarize relevant new data on this topic presented during the 2025 ISTH Congress.</div></div>","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 8","pages":"Article 103266"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145748737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry Emicizumab,因子VIII模拟双特异性单克隆抗体:对凝血酶生成和血栓弹性测定的影响
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103237
Armando Tripodi , Marigrazia Clerici , Erica Scalambrino , Sara Arcudi , Roberta Gualtierotti , Cristina Novembrino , Flora Peyvandi

Background

Emicizumab is used for prophylaxis of patients with hemophilia A. Because it is used at a fixed dose that is not based on laboratory testing, evaluation of its activity is occasionally needed. Global coagulation procedures such as thrombin generation assays (TGAs) or thromboelastometry are obvious candidates for testing. Information on the significance of TGA or thromboelastometry parameters in patients treated with emicizumab is limited.

Objectives

We performed a 2-step study to gain insight into the pattern of variation of TGA or thromboelastometry results in patients treated with emicizumab.

Methods

The first experiment was an in vitro investigation of the best conditions in terms of TGA reagent composition needed to show the best dose-response of TGA parameters and emicizumab concentrations. In the second, we evaluated ex vivo the correlation of TGA or thromboelastometry parameters vs emicizumab concentrations achieved by patients receiving prophylaxis.

Results

While TGA thrombin peak and endogenous thrombin potential (ETP) showed good dose-response with emicizumab concentrations, lag time and time-to-peak did not. The best TGA condition in terms of reagent composition was 1 pM tissue factor plus 1 μM phospholipids. There was a strong correlation between thrombin peak or ETP and emicizumab concentrations. The correlation was highly significant for thromboelastometry clotting time, but only when the procedure was performed without exogenous triggers. Based on the above correlations, we estimated the value of TGA or thromboelastometry parameters corresponding to the critical values of 40 or 80 μg/mL emicizumab.

Conclusion

TGA thrombin peak or ETP performed at low tissue factor and phospholipid concentrations should be used to evaluate emicizumab activity. Thromboelastometry clotting time is valuable when performed without exogenous triggers.
demicizumab用于a型血友病患者的预防,因为它以固定剂量使用,而不是基于实验室测试,因此偶尔需要评估其活性。全球凝血程序,如凝血酶生成测定(TGAs)或血栓弹性测定是明显的候选测试。关于TGA或血栓弹性测量参数在接受emicizumab治疗的患者中的意义的信息是有限的。目的:我们进行了一项两步研究,以深入了解接受emicizumab治疗的患者TGA或血栓弹性测量结果的变化模式。方法第一个实验是体外研究TGA试剂组成的最佳条件,以显示TGA参数和emicizumab浓度的最佳剂量反应。在第二项研究中,我们评估了TGA或血栓弹性测量参数与接受预防治疗的患者获得的艾美珠单抗浓度的体外相关性。结果TGA凝血酶峰和内源性凝血酶电位(ETP)随emicizumab浓度的变化呈现出良好的剂量反应,但滞后期和峰值时间没有表现出良好的剂量反应。在试剂组成方面,最佳TGA条件为1 pM组织因子+ 1 μM磷脂。凝血酶峰值或ETP与半蜜单抗浓度之间存在很强的相关性。这种相关性对于血栓弹性测定法的凝血时间非常显著,但仅在没有外源性触发的情况下进行。基于上述相关性,我们估计了40或80 μg/mL emicizumab临界值对应的TGA或血栓弹性测量参数的值。结论在低组织因子和低磷脂浓度下,tga凝血酶峰值或ETP可用于评价半蜜单抗的活性。在没有外源性触发的情况下,血栓弹性测定法的凝血时间是有价值的。
{"title":"Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry","authors":"Armando Tripodi ,&nbsp;Marigrazia Clerici ,&nbsp;Erica Scalambrino ,&nbsp;Sara Arcudi ,&nbsp;Roberta Gualtierotti ,&nbsp;Cristina Novembrino ,&nbsp;Flora Peyvandi","doi":"10.1016/j.rpth.2025.103237","DOIUrl":"10.1016/j.rpth.2025.103237","url":null,"abstract":"<div><h3>Background</h3><div>Emicizumab is used for prophylaxis of patients with hemophilia A. Because it is used at a fixed dose that is not based on laboratory testing, evaluation of its activity is occasionally needed. Global coagulation procedures such as thrombin generation assays (TGAs) or thromboelastometry are obvious candidates for testing. Information on the significance of TGA or thromboelastometry parameters in patients treated with emicizumab is limited.</div></div><div><h3>Objectives</h3><div>We performed a 2-step study to gain insight into the pattern of variation of TGA or thromboelastometry results in patients treated with emicizumab.</div></div><div><h3>Methods</h3><div>The first experiment was an <em>in vitro</em> investigation of the best conditions in terms of TGA reagent composition needed to show the best dose-response of TGA parameters and emicizumab concentrations. In the second, we evaluated <em>ex vivo</em> the correlation of TGA or thromboelastometry parameters vs emicizumab concentrations achieved by patients receiving prophylaxis.</div></div><div><h3>Results</h3><div>While TGA thrombin peak and endogenous thrombin potential (ETP) showed good dose-response with emicizumab concentrations, lag time and time-to-peak did not. The best TGA condition in terms of reagent composition was 1 pM tissue factor plus 1 μM phospholipids. There was a strong correlation between thrombin peak or ETP and emicizumab concentrations. The correlation was highly significant for thromboelastometry clotting time, but only when the procedure was performed without exogenous triggers. Based on the above correlations, we estimated the value of TGA or thromboelastometry parameters corresponding to the critical values of 40 or 80 μg/mL emicizumab.</div></div><div><h3>Conclusion</h3><div>TGA thrombin peak or ETP performed at low tissue factor and phospholipid concentrations should be used to evaluate emicizumab activity. Thromboelastometry clotting time is valuable when performed without exogenous triggers.</div></div>","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 8","pages":"Article 103237"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145527974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HTRS2025.P2.56 Pregnancy Outcomes in Patients with Hemophilia B Carrier Status HTRS2025.P2.56 B型血友病携带者妊娠结局
IF 3.4 3区 医学 Q2 HEMATOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.rpth.2025.103076
Junaid A. Wali , Aneel Ashrani , Meera Sridharan
{"title":"HTRS2025.P2.56 Pregnancy Outcomes in Patients with Hemophilia B Carrier Status","authors":"Junaid A. Wali ,&nbsp;Aneel Ashrani ,&nbsp;Meera Sridharan","doi":"10.1016/j.rpth.2025.103076","DOIUrl":"10.1016/j.rpth.2025.103076","url":null,"abstract":"","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"9 ","pages":"Article 103076"},"PeriodicalIF":3.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145711790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Research and Practice in Thrombosis and Haemostasis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1